Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial (2019)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciy589
PubMed Identifier: 30060027
Publication URI: http://europepmc.org/abstract/MED/30060027
Type: Journal Article/Review
Parent Publication: Clinical Infectious Diseases
Issue: 7
ISSN: 1058-4838